-+ 0.00%
-+ 0.00%
-+ 0.00%

Eli Lilly's Oral GLP-1 Associated With Reduced Risk of Type 2 Diabetes, Heart Disease in Adults With Obesity

Dow Jones·10/01/2026 11:50:00

請登錄查看新聞詳情